Your session is about to expire
← Back to Search
Behavioral Intervention
Movement Pattern Biofeedback Training for Total Knee Replacement Recovery (MOVE Trial)
N/A
Waitlist Available
Led By Jennifer E Stevens-Lapsley, PT, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Underwent primary, unilateral knee arthroplasty for end-stage osteoarthritis
50-85 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks after surgery
Awards & highlights
MOVE Trial Summary
This trial is comparing a new movement pattern training program to regular rehabilitation after knee surgery, to see if the new program leads to better movement quality and function.
Who is the study for?
Adults aged 50-85 who have had a knee replacement due to severe osteoarthritis can join this study. It's not for those discharged elsewhere than home, with previous opposite knee surgery, uncontrolled diabetes, unable to walk 30m without help, other limiting conditions, certain knee pain levels or smokers.Check my eligibility
What is being tested?
The trial is testing a new training program called MOVE that uses biofeedback insoles during rehabilitation after knee replacement surgery. It aims to see if MOVE improves movement and function more than the usual rehab exercises alone.See study design
What are the potential side effects?
Since this trial involves physical therapy and exercise rather than medication, side effects may include muscle soreness or discomfort from the exercises. The biofeedback insoles are non-invasive but might cause skin irritation.
MOVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had knee replacement surgery for severe arthritis in one knee.
Select...
I am between 50 and 85 years old.
MOVE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks after surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Knee
Secondary outcome measures
Adherence to the intervention
Change in 30-Second Sit-to-Stand Test (30-STS)
Change in Accelerometer-based Physical Activity
+9 moreOther outcome measures
Change in contralateral knee whole-organ MRI scoring method (WORMS) total sum score
Incidence of contralateral TKA
MOVE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: MOVEExperimental Treatment1 Intervention
Movement pattern training in addition to contemporary progressive rehabilitation
Group II: CONTROLActive Control1 Intervention
Contemporary progressive rehabilitation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MOVE
2011
N/A
~240
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,445 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,004,976 Total Patients Enrolled
University of California, San FranciscoOTHER
2,503 Previous Clinical Trials
15,236,517 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe pain (more than 4/10) or high-grade arthritis in my other knee.I do not have health conditions that would stop me from participating in physical rehab.I had knee replacement surgery for severe arthritis in one knee.I have bone problems that limit my movement.I had surgery complications that changed my rehab plan.I cannot walk 30 meters by myself without help.I have had a total knee replacement on the opposite knee.I am between 50 and 85 years old.I will be discharged to a place that is not my home after surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental: MOVE
- Group 2: CONTROL
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are research volunteers still being enrolled for this experiment?
"As indicated on clinicaltrials.gov, this investigation is currently recruiting participants. It was initially listed on the 19th of January 2018 and last amended on the 1st of November 2022."
Answered by AI
What is the maximum capacity for participants in this research?
"Affirmative, the information found on clinicaltrials.gov suggests that this medical experiment is currently attempting to find suitable applicants. It was posted on January 19th 2018 and amended most recently on November 1st 2022. Currently it requires 150 volunteers from a single location."
Answered by AI
Are individuals less than 55 years of age allowed to be part of this research experiment?
"This medical trial's inclusion criteria has been set so that the youngest enrollees must be 50 years old, while those aged 85 or above are not eligible."
Answered by AI
Is my profile compatible with participating in this clinical experiment?
"Applicants to this clinical study must have undergone total knee arthroplasty (TKA) and be aged between 50 and 85. Approximately 150 patients will be accepted into the trial."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger